425: Strive Warns on Semler Merger Risks & Integration Challenges

Strive, Inc. issued a cautionary statement regarding its proposed business combination with Semler Scientific, Inc., highlighting inherent risks and uncertainties.

Summary

• Strive, Inc. (Strive) and Semler Scientific, Inc. (Semler Scientific) are engaged in a proposed business combination.
• The communication, reposted by Ben Werkman, Strive's CIO, on December 11, 2025, serves as a cautionary statement regarding forward-looking statements related to the merger.
• Forward-looking statements include expectations for strategic and financial benefits, impact on future financial performance, closing timing, and successful integration.
• The companies explicitly state that actual results could differ materially from anticipated results due to various risks and uncertainties.
• Investors and stockholders are urged to read the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus when available for important information.

Sentiment

Score: 5

Explanation: The filing is a cautionary statement primarily focused on outlining risks and uncertainties associated with a proposed merger, rather than announcing positive developments or financial results. While the intent of the merger is positive, the emphasis is on potential challenges, leading to a neutral to slightly cautious sentiment.

Positives

• The proposed transaction is intended to yield strategic and financial benefits for the combined company.
• Management anticipates a positive impact on the combined company's future financial performance.

Negatives

• There is a possibility that the proposed transaction may not close as expected or at all.
• Anticipated benefits, including cost savings and strategic gains, may not be realized.
• Integration of the two companies could be more difficult, time-consuming, or costly than expected.
• The transaction may be more expensive or take longer to complete than anticipated.
• Dilution of Strive's Class A common stock is expected due to the issuance of additional shares for the transaction.

Risks

• The occurrence of any event, change, or circumstances that could lead to the termination of the merger agreement.
• Conditions to closing the proposed transaction may not be received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized when expected or at all.
• Risks associated with the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and changes in laws and regulations and their enforcement.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The outlook for the proposed transaction between Strive and Semler Scientific includes expectations for strategic and financial benefits, a positive impact on the combined company's future financial performance, and successful integration. However, these are forward-looking statements subject to significant risks and uncertainties, and actual results may differ materially from these projections.

Management Comments

• Ben Werkman, Chief Investment Officer of Strive, Inc., reposted the communication on X.com on December 11, 2025, in connection with the proposed business combination.

Industry Context

This announcement is specific to the proposed merger between Strive and Semler Scientific and does not provide broader industry context or trends.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a risk factor.

Stakeholder Impact

• Shareholders of Strive face potential dilution due to the issuance of additional Class A common stock.
• Shareholders of both companies may experience changes in share price before closing.
• Customers of Strive and Semler Scientific may have adverse reactions to the proposed transaction.
• Employee relationships at both companies could change as a result of the announcement or completion of the proposed transaction.

Next Steps

• Strive will file a definitive Information Statement/Proxy Statement/Prospectus with the SEC.
• Semler Scientific stockholders will be sent the definitive Information Statement/Proxy Statement/Prospectus to seek their approval of the proposed transaction.

Key Dates

Keywords

Merger, Acquisition, Strive Inc., Semler Scientific Inc., SEC Filing, Form 425, Business Combination, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Strategy